ATR Pathway Inhibition Is Synthetically Lethal in Cancer Cells with ERCC1 Deficiency

Published 2014 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
ATR Pathway Inhibition Is Synthetically Lethal in Cancer Cells with ERCC1 Deficiency
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 74, Issue 10, Pages 2835-2845
Publisher
American Association for Cancer Research (AACR)
Online
2014-03-25
DOI
10.1158/0008-5472.can-13-3229

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.